SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,682,507 | +28.4% | 177,622 | +16.5% | 0.08% | +31.7% |
| Q2 2023 | $29,353,233 | -6.1% | 152,523 | -1.2% | 0.06% | -13.7% |
| Q1 2023 | $31,244,360 | +40.3% | 154,316 | -11.0% | 0.07% | +25.9% |
| Q4 2022 | $22,276,222 | -5.3% | 173,357 | +0.7% | 0.06% | -7.9% |
| Q3 2022 | $23,535,000 | -27.6% | 172,071 | -6.3% | 0.06% | -24.1% |
| Q2 2022 | $32,489,000 | -32.0% | 183,614 | -44.7% | 0.08% | +62.7% |
| Q1 2022 | $47,794,000 | -5.6% | 331,780 | +2.4% | 0.05% | -52.8% |
| Q4 2021 | $50,624,000 | -13.1% | 324,055 | -5.5% | 0.11% | -26.5% |
| Q3 2021 | $58,230,000 | +2.4% | 342,929 | -4.8% | 0.15% | -7.5% |
| Q2 2021 | $56,888,000 | +20.8% | 360,320 | +6.2% | 0.16% | -3.0% |
| Q1 2021 | $47,111,000 | +207.0% | 339,271 | +287.2% | 0.16% | +187.7% |
| Q4 2020 | $15,348,000 | – | 87,632 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |